← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 2013-12-19

Drug application

FDA Application #

ANDA203611

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

Gabapentin

Active ingredients

GABAPENTIN

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

ACTAVIS ELIZABETH

First approval

2013-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown